Evaluation and Management of Hypertensive Disorders of Pregnancy.
Evaluation and Management of Hypertensive Disorders of Pregnancy.
复制标题
DOI：
10.34067/kid.0000000000000228
复制
发表时间：
2023-10-01
期刊：
影响因子：
--
通讯作者：
Shah S
中科院分区：
文献类型：
--
作者：
Bajpai D;Popa C;Verma P;Dumanski S;Shah S
妊娠期高血压疾病使多达10%的妊娠并发症，并且仍然是孕产妇和新生儿发病率和死亡率的主要原因。妊娠期高血压疾病可根据高血压发作和靶器官受累的情况分为四组：慢性高血压、先兆子痫、妊娠期高血压和慢性高血压叠加先兆子痫。妊娠期高血压与心血管疾病和肾衰竭的风险较高有关。对患有高血压的孕妇进行早期诊断和适当治疗仍然是一个优先事项，因为这会改善孕产妇和胎儿的结局。拉贝洛尔、硝苯地平、甲基多巴和肼苯哒嗪是治疗妊娠期高血压的首选药物。在这篇综述中，我们讨论了妊娠高血压的诊断标准、评估和管理。
Hypertensive disorders of pregnancy complicate up to 10% of pregnancies and remain the major cause of maternal and neonatal morbidity and mortality. Hypertensive disorders of pregnancy can be classified into four groups depending on the onset of hypertension and the presence of target organ involvement: chronic hypertension, preeclampsia, gestational hypertension, and superimposed preeclampsia on chronic hypertension. Hypertension during pregnancy is associated with a higher risk of cardiovascular disease and kidney failure. Early diagnosis and proper treatment for pregnant women with hypertension remain a priority since this leads to improved maternal and fetal outcomes. Labetalol, nifedipine, methyldopa, and hydralazine are the preferred medications to treat hypertension during pregnancy. In this comprehensive review, we discuss the diagnostic criteria, evaluation, and management of pregnant women with hypertension.